In this paper, we propose a named entity recognition system for biomedical literature using two-layer support vector machines. In addition, we employ a post-processing module called a boundary check module to eliminate some boundary errors, which can lead to improved system performance. Our system doesn't make use of any external lexical resources and hence it is a fairly simple system. Furthermore, with carefully designed features and introducing a second layer, our system can recognize named entities in biomedical literature with fairly high accuracy, which can achieve the precision of 83.5%, recall of 80.8% and balanced F β=1 score of 82.1%, an approximate state of the art performance for the moment.
INTRODUCTION
In recent years, there is a growing interest in genome research. Hence the amount of biomedical literature published daily is increasing exponentially. For example, MEDLINE (MEDLINE, 1966) , the primary research database in biomedical domain, is an online bibliographic source of citations and abstracts dating from 1966 till present and now contains more than 14 million abstracts. Therefore, extracting information from the biomedical literature manually is not realistic any more and an urgent demand for automated information extraction system in biomedical domain has emerged.
The focus of this paper is on named entity recognition (NER) in biomedicine. Named entities in biomedicine include names of genes, proteins, gene products, organisms, etc. NER is an important first step for information extraction in biomedical literature. Without precise recognition of these named entities, it is impossible to extract the relations, information and knowledge from the literature. However, due to the complex biomedical nomenclature, NER in biomedicine is often much more difficult than that in newswire domain. For example, named entities can be full names (such as "fatty acid synthase") or abbreviations (such as "FAS"). Even worse, sometimes abbreviations are not acronyms. Moreover, a given named entity can have several aliases (e.g., a gene for nerve growth factor receptor has at least 10 different names). In order to handle these difficulties, many different approaches have been applied in the past few years, Support Vector Machines (SVMs) (Mitsumori et al., 2005; Takeuchi and Collier, 2003) , Hidden Markov Models (HMMs) (Zhou et al., 2005; Morgan et al., 2004) and rule-based systems (Tamames, 2005; Tanabe and Wilbur, 2002) . In general, there are 2 divisions for NER systems in biomedicine.
• Closed: The system is only trained on the training data without any external lexicon.
• Open: The system can make use of external lexical resources.
Usually open systems are more complicated than closed ones because open systems need incorporate external lexicons. Moreover, it is not trivial to utilize the lexicons properly, which heavily depends on how to constitute the lexicons and how to design the lexicon matching strategies. Some papers (Kinoshita et al., 2005; Zhou et al., 2005) reported that adding the lexicons could improve the performance while other papers (Song et al., 2004; Tsuruoka and Tsujii, 2003) claimed that the performance even decreased after incorporating the lexicons.
Here we propose a closed system for recognizing named entities from biomedical literature using twolayer support vector machines without utilizing any external lexicon. Our system is efficient due to its simplicity and also effective because it can achieve over 80% balanced F β=1 score, an approximate state of the art performance currently. We will discuss it in detail in Section 2. Figure 1 shows our named entity recognition system. We employ two SVMs to build a two-layer NER system. The first layer is from text to entity, which takes original text as input and recognizes named entities from text. Then the second layer is from entity to entity, which takes named entities from the first layer as input, makes some corrections and outputs the final recognition. 
METHOD

Overview
Support Vector Machines
SVM (Vapnik, 1995) is a powerful machine learning method, which was introduced by Vladimir Vapnik and his colleagues in 1995. In SVM learning, the data is mapped non-linearly from the original input space X to a high-dimensional feature space F. Due to the non-linear mapping to F, the complex non-linear decision boundary in X becomes the simple linear decision boundary in F. Moreover, by introducing the kernel function K, the mapping to F can stay implicit and we can avoid working in the high-dimensional space F; i.e., inner products in F can be directly calculated by K taking vectors from the input space X and without having to know the exact form of the mapping, hence the implicit mapping and computational benefit. Finally, the decision boundary is defined completely by inner products between vectors in F and calculated through the kernel function K. Therefore, in SVM learning, the most important design decision is the choice of kernel function K.
In this paper we choose the toolbox LIBSVM (Chang and Lin, 2001 ), a Jave/C++ library for SVM learning, to implement our system. And we adopt the following polynomial kernel as the kernel function:
with coe f = 0 and d = 2
Data Representation
The data used in our experiments is taken from the training data of BioCreAtIvE II challenge (BioCreAtIvE, 2006), which consist of 15000 sentences derived from MEDLINE abstracts that have been manually annotated for names of genes/proteins and their related entities. The first pre-processing step is tokenization. Unlike NER systems in newswire domain, here we can't remove punctuation to make processing straightforward because many gene/protein names contain hyphens, parentheses, brackets and other type of punctuation. Hence we split the sentences based on spaces and punctuation. For example, an sentence "the M-phase-inducing Cdc2/Cdc13 cyclin-dependent kinase" is tokenized into the following tokens: "the", "M", "-", "phase", "-", "inducing", "Cdc2", "/", "Cdc13", "cyclin", "-", "dependent", "kinase".
Then the second pre-processing step is assigning the class label for each token. We use the traditional BIO representation as follows.
• B: current token is the beginning of a named entity
• I: current token is inside a named entity
• O: current token is outside a named entity
Consider that "Cdc2/Cdc13 cyclin-dependent kinase" is a named entity.
Therefore after preprocessing, the above sentence becomes "O the", "O M", "O -", "O phase", "O -", "O inducing", "B Cdc2", "I /", "I Cdc13", "I cyclin", "I -", "I dependent", "I kinase".
Feature Extraction
In the first layer, the following features are extracted to represent each token.
• Token: token itself.
• Orthographic feature: Table 1 shows all the 22 orthographic features used in our system.
• POS: Part-of-speech of the current token. POS can determine the syntactic functions of words in text, which are very helpful for NER systems. However, POS taggers developed for newswire domain don't perform well when applied to biomedical literature. Hence we use the MedPost tagger (Smith et al., 2004) in our system. MedPost was trained on the MEDLINE corpus so that it can achieve over 97% accuracy on MED-LINE citations.
• Prefix: bi-, tri-and quad-prefix of the current token. For instance, the bi-, tri-and quad-prefix of the token "transaminase" are "tr", "tra" and "tran", respectively.
• Suffix: bi-, tri-and quad-suffix of the current token. Similarly, the bi-, tri-and quad-suffix of "transaminase" are "se", "ase" and "nase", respectively. Therefore each token can be represented by the above 9 features. Furthermore, by sliding windows, i.e., taking into account a few tokens before and after the current token, we can retrieve the relevant information from the neighboring tokens surrounding the current token.
In the second layer, we only use one feature, the predicted class labels from the first layer, and also make use of sliding windows.
Post Processing
In order to improve the performance further, we employ a post-processing module called a boundary check module, which can recover the following kinds of boundary errors.
• Boundary errors caused by our BIO representation: By identifying the label B, the system can determine the beginning of the named entity. However, sometimes the system fails to recognize the label B. So we develop some rules to recover the label B based on the neighboring tokens. For example, a sample phrase "maternal alpha fetoproteins" is recognized into "O maternal", "I alpha" and "I fetoproteins". According to the labels of "alpha" and "fetoproteins", the label of "maternal" is reassigned to "B".
• Boundary errors due to punctuation: -, +, /, ., etc. For instance, a phrase "c-myc protein" is recognized into "O c", "B -", "I myc" and "I protein". In order to recover the integrity, the labels of "c" and "-" need to be changed into "B" and "I", respectively.
• Boundary errors due to missing trigger words: Depending on the annotation guidelines of BioCreAtIvE challenge, some words need to considered as part of names, e.g., receptor, enhancer, promoter, mutant, etc. Hence, for example, if only "FSH" in "FSH receptor" is recognized as a named entity, we will add "receptor" into it.
RESULTS
The final system is trained on the whole data (15000 sentences). We preform a 5-fold cross validation using 80% of the data as training data and the remaining as test data. For the parameter selection, we try a wide range of SVM cost parameter C from 2 −10 to 2 NER systems are often evaluated by means of the precision, recall and balanced F β=1 score, which are defined as follows. "T P", "FP" and "FN" are the numbers of true positives, false positives and false negatives.
Next, we will present our results and compare them to other methods that have been applied on the mostly similar data set, which are shown in Table 2 as follows. (Song et al., 2004) , (Mitsumori et al., 2005) , (Tamames, 2005) , (Kinoshita et al., 2005) and (Zhou et al., 2005) respectively.
PosBIOTM-Ner and Yamcha are both based on SVM algorithm and BIO representation, the same as our system. PosBIOTM-Ner makes use of editdistance as a significant contributing feature for SVM while Yamcha uses an external lexicon composed of SWISS-PROT and TrEMBL data. From Table 2 , it can be easily seen that our system based on two-layer SVMs can outperform these two systems, i.e., F β=1 score is 8.3% higher than PosBIOTM-Ner and 4% higher than Yamcha. Also our system can achieve better performance than Rule-based and HMM-based taggers.
Notice that our system performs a little worse than PowerBioNE. We've achieved 1.5% higher precision but 2.4% lower recall, which leads to 0.5% lower F β=1 score. This is not surprising for us because PowerBioNE is a complex system, which is an ensemble of classifiers in which three classifiers, one SVM and two discriminative HMMs, are combined using a simple majority voting strategy. In addition, PowerBioNE incorporates three post-processing modules to improve the performance further. In the paper (Zhou et al., 2005) , they report that SVM classifier can get higher precision while HMM classifier can obtain higher recall. We think that is why our system has lower recall than PowerBioNE. However, considering the simplicity of our approach, our system is still comparable to PowerBioNE.
In a word, our system can outperform most of above systems and achieve an approximate state of the art result, though it is relatively simple and doesn't utilize any external lexical resources.
DISCUSSION
In the following sections, we start by discussing our system in detail from different kinds of aspects. Then we will give a comprehensive error analysis.
Contributions of Different Features
The effects of each feature in the first layer in our system are shown in Table 3 . The row of "token(base)" shows the result when only the token feature is used in the SVM learning. The other rows show the results when the token feature plus one other feature are used in the learning, i.e.,"+orthographic" means the token plus the orthographic feature; "+POS" means the token feature plus the MedPost POS feature; "+bi-prefix/suffix" means the token feature plus the biprefix and bi-suffix features, etc. From Table 3 , it shows that the orthographic feature and the bi-prefix/suffix feature are critical for our system, which improve F β=1 score by 13.8% and 9.9% compared with the base. Moreover, most of the features in Table 3 can't affect the precision so much while they mostly have great effects on the recall.
Then, as mentioned above, we use MedPost for POS tagging, which was trained on the MEDLINE corpus. To demonstrate the effects of using different POS taggers in our system, we replace MedPost with TreeTagger (Schmid, 1994) , which was trained on newswire articles, to retrain our system. The results are shown in Table 4 . It can be seen that MedPost performs slightly better than TreeTagger but the difference is too small to be significant. Together with the results from Table 3 , we can conclude that the POS feature can't affect our system very much.
Contributions of the Second Layer
Introducing a second layer isn't unusual. A similar approach has been applied successfully in protein secondary structure prediction (Rost, 2003) . Our system performs prediction in two layers, where the first layer is a text to entity step and the second layer is a entity to entity step, i.e., the named entities that are predicted in the first layer are fed to a new classifier in the second layer. Table 5 shows the detailed results of various layers in our system. Table 5 , it is clear that the precision, recall and F β=1 score are increased by 4.1%, 0.9% and 2.4% respectively, which means that the second layer can improve the performance of our system greatly. We think the reason is that based on the prior prediction from the first layer and making use of sliding windows, our system can output more refined named entities according to the prior prediction together with its neighbors.
Effect of Post Processing
We carry out a boundary check post-processing module to make sure the integrity of the named entities. Table 6 shows the performance of the boundary check module.
In NER systems, boundary errors of named entities are very critical because they can increase both false positive errors and false negative errors. We can elaborate it by the following example. Suppose that a sample phrase "NF-kappa Bp50" is recognized wrongly to "O NF", "B -", "I kappa" and "I Bp50", which leads to both a false positive error ("-kappa Bp50" isn't a gene/protein name) and a false negative error ("NF-kappa Bp50" isn't recognized correctly). Therefore, it is essential to introduce a boundary check module in our system.
From Table 6 , it is clear that the precision, recall and F β=1 score are increased by 2.4%, 1.6% and 2.0%, respectively. This means that the boundary check module can effectively correct some boundary errors and consequently improve the performance of our system further.
Error Analysis
Finally, we conduct an error analysis to find out where our system can be improved in the future. We categorize all the errors into 5 classes.
• boundary errors only occur on the left side, which are those errors with the correct right boundary but the incorrect left boundary.
• boundary errors only occur on the right side, which are those errors with the correct left boundary but the incorrect right boundary.
• boundary errors occur on both sides, which are those errors with both the wrong right boundary and the wrong left boundary.
• non-boundary false positive errors are those errors which are wrongly recognized into named entities and don't contain any boundary errors.
• non-boundary false negative errors are those errors which are missed being identified to named entities and don't contain any boundary errors.
Figures 2 and 3 show the distribution of the above 5 kinds of errors before and after a boundary check module, respectively.
Boundary errors may be the easiest ones to solve because at least our system has correctly recognized part of the named entities, which can give useful clues to correct the errors. Through comparing Figures 2  and 3 , the boundary check module indeed can reduce some boundary errors, about 2% less on average. But we need optimize this module further since there are still 27% boundary errors left in our system.
The remaining 73% errors are composed of false positive errors (33%), which often occur when a noun phrase is a generic term ("mRNA", "gene") or mixed with digits and capitals ("W85"), and false negative errors (40%), which often occur when our system has little related information and context clues.
CONCLUSION
In this paper, we first propose a named entity recognition system for biomedical literature using twolayer support vector machines and then present a postprocessing module called a boundary check module to improve the performance further. The results show that with carefully designed features and introducing a second layer, our system can recognize named entities with fairly high accuracy, even without using external lexicons.
In the future, we will consider more modules to resolve the abbreviations, the aliases, etc. Furthermore, we will explore appropriate approaches to make use of external knowledge resources, e.g., lexicons, full MEDLINE abstracts and web searches.
